Prof. Jana Tchekalarova | Toxicology | Best Research Article Award
scientist at Institute of Neurobiology Bulgarian Academy of Sciences, Bulgaria
Prof. Jana Tchekalarova is a distinguished academic and researcher in the field of pharmacology and neurobiology. She has been a Professor of Pharmacology since 2016 and previously held the position of Associate Professor in Pharmacology starting in 2010. Her research career began with a postdoctoral position at the Institute of Neurobiology, Bulgarian Academy of Sciences, where she worked from 2004 to 2010. Prof. Tchekalarova earned her Ph.D. in pharmacology from the Bulgarian Academy of Sciences between 2000 and 2004. She also holds a Masterās degree from the Institute of Biophysics, Bulgarian Academy of Sciences, and a Bachelorās degree in Biochemistry and Microbiology from the University of Sofia āSt. Kliment Ohridski.ā
Professional Profiles:
Education:
Prof. Jana Tchekalarova has a distinguished educational background and qualifications in the field of pharmacology and neurobiology. She has been a Professor in Pharmacology since 2016, following her promotion to Associate Professor in Pharmacology in 2010. From 2004 to 2010, she served as a postdoctoral researcher at the Institute of Neurobiology, Bulgarian Academy of Sciences in Sofia. Her academic journey includes a Ph.D. in pharmacology, which she pursued from 2000 to 2004 at the Bulgarian Academy of Sciences. Prof. Tchekalarova also holds a Masterās degree from the Institute of Biophysics, Bulgarian Academy of Sciences, earned in 1989-1990. Her foundational education includes a Bachelorās degree in Biochemistry and Microbiology from the University of Sofia āSt. Kliment Ohridski,ā completed between 1985 and 1989.
Professional Experience:
Prof. Jana Tchekalarova has held several prominent positions throughout her career. Since 2022, she has been serving as a Member of the Management Board of the Bulgarian Academy of Sciences. In 2020, she assumed the role of Scientific Secretary at the Institute of Neurobiology, Bulgarian Academy of Sciences. She has been the Head of the Department of Behavioral Neurobiology at the same institute since 2018. Additionally, she has held the position of Vice Director of the Institute of Neurobiology since 2021. Prof. Tchekalarova also contributes to academia as a part-time teacher at the Medical Faculty of Sofia University, a role she has held since 2015.
Research Awards:
Prof. Jana Tchekalarova has been the recipient of numerous research awards and fellowships throughout her career. From 1999 to 2000, she was awarded a fellowship funded by the Greek Ministry for Development/General Secretariat for Research & Technology/Joint Research and Technology Programs/Bulgaria-Greece Collaborations (work #6824). In 2000, she received a fellowship within the NATO Science Fellowship Programme. In 2005, Prof. Tchekalarova was granted a fellowship funded by CEERC IBRO. She also received a fellowship funded by the DFG in Germany in 2009, and in 2010, she was awarded a fellowship funded by the Japan Society for the Promotion of Science.
Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models
V. Angelova, V. Karabeliov, P.A. AndreevaāGateva, J. Tchekalarova
Drug Development Research 77 (7), 379-392
75 citations
2016
Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress
D.M. Pechlivanova, J.D. Tchekalarova, L.H. Alova, V.V. Petkov, R.P. Nikolov, …
Behavioural Pharmacology 23 (4), 339-347
74 citations
2012
Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats
D. Pechlivanova, J. Tchekalarova, R. Nikolov, K. Yakimova
Behavioural Brain Research 209 (2), 205-211
67 citations
2010
Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?
J. Tchekalarova, V. Georgiev
Life Sciences 76 (9), 955-970
65 citations
2005
Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light
J. Tchekalarova, T. Stoynova, K. Ilieva, R. Mitreva, M. Atanasova
Pharmacology Biochemistry and Behavior 171, 1-9
64 citations
2018
Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy
J. Tchekalarova, Z. Petkova, D. Pechlivanova, S. Moyanova, L. Kortenska, …
Epilepsy & Behavior 27 (1), 174-187
63 citations
2013
Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy
J. Tchekalarova, D. Pechlivanova, T. Atanasova, P. Markova, V. Lozanov, …
Epilepsy & Behavior 20 (2), 277-285
57 citations
2011
Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy
J.D. Tchekalarova, N.M. Ivanova, D.M. Pechlivanova, D. Atanasova, …
Pharmacology Biochemistry and Behavior 127, 27-36
55 citations
2014
Oxidative stress and aging as risk factors for Alzheimerās disease and Parkinsonās disease: the role of the antioxidant melatonin
J. Tchekalarova, R. Tzoneva
International Journal of Molecular Sciences 24 (3), 3022
51 citations
2023
Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis
J. Tchekalarova, H. Kubova, P. MareÅ”
Behavioural Brain Research 160 (1), 99-106
51 citations
2005